Darbelife 25mcg Pfs Injection
Marketer
Hetero Drugs Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Darbelife 25mcg Pfs Injection
Darbepoetin alfa 25mcg PFS injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. This medication requires careful administration due to potential serious adverse reactions; expert medical supervision is crucial. Strict adherence to physician instructions is mandatory. Administered under professional healthcare oversight, common side effects include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report severe headaches, visual disturbances, nausea, vomiting, or convulsions (indicative of dangerously high blood pressure) to your physician immediately. Regular blood tests, monitoring electrolytes (potassium), hemoglobin, and blood cell counts, are typically conducted. Discontinue use and seek immediate medical attention if shortness of breath or a skin rash develops. Prior to commencing treatment, inform your doctor of any pre-existing heart conditions, hypertension, seizure history, or stroke history. Pregnant or breastfeeding individuals, or those planning pregnancy or breastfeeding, must consult their physician regarding the medication's safety profile.
Primary Ingredients of Darbelife 25mcg Pfs Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Darbelife 25mcg Pfs Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Darbelife 25mcg Pfs Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Darbelife 25mcg Pfs Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbelife 25mcg Pfs Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Darbelife 25mcg Pfs Injection works:
Darbepoetin alfa 25 mcg prefilled syringe is a medication that boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts on the bone marrow to increase the formation of red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbelife 25mcg Pfs Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Darbelife 25mcg Pfs Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Darbelife 25mcg Pfs Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication's transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Administering Darbelife 25mcg Pfs Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Darbelife 25mcg Pfs Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with liver impairment should use Darbelife 25mcg Pfs Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Darbelife 25mcg Pfs Injection :
Should you forget a Darbelife 25mcg Pfs Injection, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbelife 25mcg Pfs Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Erythropoietin-stimulating drug |
3,018 People bought this recently